Ekso Bionics Inc. (EKSO)
NASDAQ: EKSO
· Real-Time Price · USD
3.07
-0.12 (-3.76%)
At close: Aug 15, 2025, 2:37 PM
Ekso Bionics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -11.09M | -10.79M | -11.33M | -11.13M | -12.42M | -14.24M | -15.2M | -15.16M | -16.1M | -14.85M | -15.08M | -14.77M | -12.42M | -10.71M | -9.76M | -10.88M | -6.47M | -16.96M |
Depreciation & Amortization | 1.56M | 1.58M | 1.61M | 1.89M | 1.82M | 1.69M | 1.7M | 1.28M | 1.11M | 1.17M | 887K | 762K | 750K | 566K | 561K | 586K | 573K | 582K |
Stock-Based Compensation | 1.31M | 1.48M | 1.63M | 1.8M | 1.85M | 2.12M | 2.24M | 2.65M | 2.71M | 2.69M | 2.73M | 2.59M | 2.7M | 2.65M | 2.5M | 2.49M | 2.37M | 2.32M |
Other Working Capital | 530K | -52K | -527K | 91K | -209K | 889K | 1.7M | 733K | 1.15M | 304K | -1.01M | -287K | -665K | -670K | 296K | -846K | -114K | -493K |
Other Non-Cash Items | -412K | 2.62M | 3.91M | 2.55M | 3.25M | 1.57M | -207K | -1.41M | -872K | -1.18M | -647K | 813K | 198K | 478K | 134K | 4K | -31K | 307K |
Deferred Income Tax | n/a | n/a | n/a | -382K | n/a | n/a | n/a | 382K | n/a | n/a | n/a | -1.7M | -2.55M | -4.64M | -4.12M | -1.55M | -5.32M | 5.23M |
Change in Working Capital | 254K | -823K | -2.52M | -1.58M | -2.44M | -969K | -583K | -1.86M | -189K | -2.52M | -2.58M | -1.82M | -2.68M | -1.71M | -468K | -478K | 262K | -513K |
Operating Cash Flow | -9.12M | -8.35M | -9.85M | -10M | -11.07M | -11.31M | -12.05M | -14.11M | -13.35M | -14.7M | -14.69M | -14.12M | -14M | -13.36M | -11.16M | -9.82M | -8.62M | -9.03M |
Capital Expenditures | -29K | -29K | -37K | -59K | -68K | -123K | -157K | -167K | -291K | -61K | -19K | 35K | 116K | -59K | -59K | -60K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 19K | 19K | 19K | 19K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -50K | -10K | n/a | -157K | -157K | -157K | -157K | -5M | -5M | -5M | -5M | -59K | -59K | -59K | -59K | n/a | n/a | n/a |
Investing Cash Flow | -79K | -39K | -37K | -59K | -68K | -123K | -157K | -5.15M | -5.27M | -5.04M | -5.18M | -141K | -60K | -235K | -59K | 5.52M | 5.58M | 5.58M |
Debt Repayment | -938K | -1.25M | -1.25M | -938K | -625K | -313K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5K | 877K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -226K | -226K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.69M | 3.75M | n/a | -313K | -313K | -313K | -313K | n/a | n/a | n/a | -176K | -176K | -176K | -176K | 1.42M | 4.21M | 6.76M | 7.54M |
Financial Cash Flow | 8.52M | 7.64M | 7.77M | 8.43M | 3.74M | 4M | 348K | 176K | 176K | 352K | 528K | 352K | 352K | 176K | 38.71M | 33.13M | 35.68M | 44.42M |
Net Cash Flow | -643K | -745K | -2.15M | -1.65M | -7.42M | -7.48M | -11.89M | -19.24M | -18.61M | -19.9M | -19.88M | -14.26M | -14.03M | -13.36M | 27.54M | 28.89M | 32.68M | 41.02M |
Free Cash Flow | -9.15M | -8.37M | -9.88M | -10.06M | -11.14M | -11.43M | -12.21M | -14.28M | -13.64M | -14.76M | -14.71M | -14.08M | -13.89M | -13.42M | -11.21M | -9.88M | -8.62M | -9.03M |